Detalhe da pesquisa
1.
The changing spectrum of infection with BCMA and GPRC5D targeting bispecific antibody (bsAb) therapy in patients with relapsed refractory multiple myeloma.
Haematologica
; 109(3): 906-914, 2024 Mar 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37646658
2.
The role of surface molecule CD229 in Multiple Myeloma.
Clin Immunol
; 204: 69-73, 2019 07.
Artigo
Inglês
| MEDLINE | ID: mdl-30326256
3.
Corneal toxicity with belantamab mafodotin: Multi-institutional real-life experience.
Am J Hematol
; 97(12): E451-E453, 2022 12.
Artigo
Inglês
| MEDLINE | ID: mdl-36097868
4.
Clinical efficacy of sequencing CD38 targeting monoclonal antibodies in relapsed refractory multiple myeloma: A multi-institutional experience.
Am J Hematol
; 97(7): E276-E280, 2022 07.
Artigo
Inglês
| MEDLINE | ID: mdl-35472167
5.
Current Strategies for the Immunotherapy of Multiple Myeloma.
Oncology (Williston Park)
; 31(1): 55-63, 2017 01 15.
Artigo
Inglês
| MEDLINE | ID: mdl-28090624
6.
Preventive azithromycin treatment reduces noninfectious lung injury and acute graft-versus-host disease in a murine model of allogeneic hematopoietic cell transplantation.
Biol Blood Marrow Transplant
; 21(1): 30-8, 2015 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-25445642
7.
Autologous stem cell boost improves persistent immune effector cell associated hematotoxicity following BCMA directed chimeric antigen receptor T (CAR T) cell therapy in multiple myeloma.
Bone Marrow Transplant
; 59(5): 647-652, 2024 May.
Artigo
Inglês
| MEDLINE | ID: mdl-38361116
8.
Blood and marrow transplant within 4 weeks of SARS-CoV-2 infection is associated with increased risk of mortality: a National COVID Cohort Collaborative (N3C) Study.
Bone Marrow Transplant
; 59(1): 121-124, 2024 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37803198
9.
Adverse effects and non-relapse mortality of BCMA directed T cell therapies in multiple myeloma: an FAERS database study.
Blood Cancer J
; 14(1): 36, 2024 Mar 05.
Artigo
Inglês
| MEDLINE | ID: mdl-38443341
10.
Clinical outcome of patients with relapsed refractory multiple myeloma listed for BCMA directed commercial CAR-T therapy.
Bone Marrow Transplant
; 58(4): 443-445, 2023 04.
Artigo
Inglês
| MEDLINE | ID: mdl-36550200
11.
Novel anti-myeloma immunotherapies targeting the SLAM family of receptors.
Oncoimmunology
; 6(5): e1308618, 2017.
Artigo
Inglês
| MEDLINE | ID: mdl-28638731
12.
Oscillating expression of interleukin-16 in multiple myeloma is associated with proliferation, clonogenic growth, and PI3K/NFKB/MAPK activation.
Oncotarget
; 8(30): 49253-49263, 2017 Jul 25.
Artigo
Inglês
| MEDLINE | ID: mdl-28512269
13.
Risk of infections with B-cell maturation antigen-directed immunotherapy in multiple myeloma.
Blood Adv
; 6(8): 2466-2470, 2022 04 26.
Artigo
Inglês
| MEDLINE | ID: mdl-34933344
14.
Elotuzumab as a novel anti-myeloma immunotherapy.
Hum Vaccin Immunother
; 13(8): 1751-1757, 2017 08 03.
Artigo
Inglês
| MEDLINE | ID: mdl-28604269
15.
Immunotherapies targeting CD38 in Multiple Myeloma.
Oncoimmunology
; 5(11): e1217374, 2016.
Artigo
Inglês
| MEDLINE | ID: mdl-27999737
16.
A call to arms: a critical need for interventions to limit pulmonary toxicity in the stem cell transplantation patient population.
Curr Hematol Malig Rep
; 10(1): 8-17, 2015 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-25662904
17.
In vivo vaccination effect in multiple myeloma patients treated with the monoclonal antibody isatuximab.
Leukemia
; 34(1): 317-321, 2020 01.
Artigo
Inglês
| MEDLINE | ID: mdl-31409922
18.
Murine cytomegalovirus immediate-early 1 gene expression correlates with increased GVHD after allogeneic hematopoietic cell transplantation in recipients reactivating from latent infection.
PLoS One
; 8(4): e61841, 2013.
Artigo
Inglês
| MEDLINE | ID: mdl-23596528